The Procter & Gamble Company Earnings Call Transcripts
Fiscal Year 2026
-
Q3 FY2026 saw broad-based organic sales growth and a 3% rise in core EPS, despite margin pressures from higher costs and increased investments. Guidance for the year is maintained, but full-year EPS is expected at the lower end of the range due to $1B in after-tax headwinds.
-
The conference detailed recent performance, strategic interventions, and digital transformation efforts, highlighting strong results from consumer-driven innovation and AI-enabled processes. Ongoing organizational changes and investments are expected to drive sequential improvement and position the company for future industry leadership.
-
Organic sales grew 3% in Q2 FY26, led by strong international performance, while U.S. sales declined due to inventory headwinds. FY26 guidance is unchanged, with expectations for stronger growth in the second half, driven by innovation and improved execution.
-
Q1 delivered 2% organic sales growth and 3% core EPS growth, with broad-based category and regional performance. Fiscal 2026 guidance is unchanged, with continued investment in innovation, restructuring, and productivity to drive long-term growth and value creation.
Fiscal Year 2025
-
U.S. and Western Europe face volatility and muted growth, while China and Latin America show strong momentum. Innovation, restructuring, and AI adoption are central to driving future growth, with a focus on core brands and consumer insights. M&A will be selective and strategic.
-
The meeting covered strong financial results, board transitions, and a continued focus on sustainability and strategic growth. All board and management proposals passed, while a shareholder proposal on flexible plastic packaging reporting was rejected. Dividend increases and ESG progress were highlighted.
-
Market growth is stable but below historical averages, with innovation and pricing strategies tailored to each region. Organizational redesign and supply chain automation are underway to boost agility and productivity. Leadership remains focused on strategic continuity and driving growth through innovation.
-
Organic sales and core EPS grew 2% and 4% respectively in fiscal 2025, with broad-based category and regional growth despite macroeconomic and geopolitical headwinds. A two-year restructuring program will streamline operations and support continued innovation, while fiscal 2026 guidance reflects ongoing volatility, including a $1B tariff headwind.
-
Consistent top and bottom-line growth continues despite increased volatility and slower market growth. A two-year restructuring program will streamline operations, reduce workforce, and focus on innovation and productivity to capture $20B-$25B in market opportunities. Most restructuring benefits are expected in FY27.
-
Organic sales grew 1% amid consumer and retailer volatility, with strong innovation and market share resilience. Fiscal year guidance calls for 2% organic sales growth and 2%-4% core EPS growth, while tariff and cost headwinds remain key risks.
-
The conference highlighted strong multi-year growth, robust innovation, and disciplined strategy execution amid ongoing global volatility. Key innovations and digital advancements are driving category leadership, while financial guidance remains focused on long-term balanced growth.
-
Organic sales grew 3% with broad-based category gains and strong North America and Europe performance, while China showed signs of recovery. Core EPS rose 2% to $1.88, but FX and commodity headwinds are expected to pressure results toward the lower end of guidance. Innovation and productivity remain key levers.
-
Solid quarterly results with 2% organic sales growth, strong North America and Europe performance, and continued innovation. China and Middle East remain volatile, but guidance for fiscal 2025 is maintained, with plans to return up to $17 billion to shareholders.
Fiscal Year 2024
-
Management outlined strong growth opportunities in core categories, driven by innovation, productivity, and superior consumer value. Despite regional volatility and short-term operational challenges, sequential sales and share gains are expected, supported by technology and targeted marketing.
-
A dynamic, integrated strategy focused on superiority, productivity, and innovation is driving balanced growth, margin expansion, and strong cash returns. Significant opportunities remain in North America, Europe, and enterprise markets, with robust investment in R&D, supply chain, and digital capabilities supporting future growth.
-
The meeting covered strong financial results, a continued commitment to dividends, and strategic focus on dynamic growth. All board and management proposals passed, while the shareholder pay gap disclosure proposal was rejected.
-
Delivered strong annual results despite external headwinds, with 85% of the business normalizing to 3%-4% growth. China remains soft but stable, while innovation and productivity initiatives continue to drive long-term strategy and margin expansion.
-
Fiscal 2024 saw strong organic sales and EPS growth, margin expansion, and robust shareholder returns despite headwinds in China and select markets. Fiscal 2025 guidance calls for 3%-5% organic sales growth and 5%-7% core EPS growth, with continued investment in innovation and productivity.
-
The conference highlighted strong multi-year growth, robust productivity gains, and strategic focus on product superiority and supply chain innovation. Resilient consumer demand in key markets and targeted innovation in challenged regions underpin a cautiously optimistic outlook for 2025.